Playlist


State Children's Library Named After Bazar Amanov to Feature New Observatory
05 Apr. 04:38Plans have been announced to construct a modern observatory for the scientific study of celestial bodies at the Bazar Amanov State Children's Library in Turkmenistan. This initiative is designed to broaden the scientific horizons of young people and foster an early interest in astronomy and space exploration. The project represents a significant step in transforming traditional libraries into dynamic, multi-disciplinary learning environments.
The proposal was unveiled during a working visit by the National Leader of the Turkmen people, Gurbanguly Berdimuhamedov, to the city of Arkadag. According to reports, the modernization of the library’s facilities will include the installation of a high-powered telescope and the creation of a specialized observation room. The project is being facilitated with the support of the Charitable Fund for Assistance to Children in Need of Care, emphasizing the social and educational value of the venture.
The new observatory will provide children and students with the opportunity to conduct real-time astronomical observations under scientific guidance. By integrating technology such as telescopes and digital mapping tools, the library aims to provide a hands-on experience that complements academic learning. The facility is expected to become a hub for interactive science education, hosting workshops and stargazing events for the public.
Currently, preparatory work is underway to ensure the observatory meets international technical standards. The addition of an astronomical center to the children’s library highlights Turkmenistan’s commitment to innovative educational infrastructure. This project serves as a model for integrating science and literature, encouraging the next generation to explore the wonders of the universe through both books and direct observation.
Also read


Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.